TET2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.068400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.830800E-01
Normal-vs-Stage2
1.947210E-01
Normal-vs-Stage3
6.915600E-02
Normal-vs-Stage4
8.115600E-01
Stage1-vs-Stage2
4.891400E-01
Stage1-vs-Stage3
1.016030E-01
Stage1-vs-Stage4
5.454000E-01
Stage2-vs-Stage3
2.344000E-01
Stage2-vs-Stage4
4.151000E-01
Stage3-vs-Stage4
2.534000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.884040E-01
Normal-vs-AfricanAmerican
6.871400E-01
Normal-vs-Asian
1.782210E-01
Caucasian-vs-AfricanAmerican
3.213400E-01
Caucasian-vs-Asian
4.495600E-01
AfricanAmerican-vs-Asian
2.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.535030E-01
Normal-vs-Female
2.977800E-01
Male-vs-Female
3.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.818600E-01
Normal-vs-Age(41-60Yrs)
6.300800E-01
Normal-vs-Age(61-80Yrs)
7.491500E-02
Normal-vs-Age(81-100Yrs)
8.065700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.347400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.71151999999175E-05
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.661500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.820350E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.666100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.975600E-02
Normal-vs-Daily Drinker
8.129500E-02
Normal-vs-Weekly Drinker
1.468020E-01
Normal-vs-Occasional Drinker
3.548400E-01
Normal-vs-Social Drinker
5.121400E-01
Non Drinker-vs-Daily Drinker
8.336000E-01
Non Drinker-vs-Weekly Drinker
9.597600E-01
Non Drinker-vs-Occasional Drinker
8.231800E-02
Non Drinker-vs-Social Drinker
7.902200E-02
Daily Drinker-vs-Weekly Drinker
8.401200E-01
Daily Drinker-vs-Occasional Drinker
8.887600E-02
Daily Drinker-vs-Social Drinker
9.077800E-02
Weekly Drinker-vs-Occasional Drinker
2.019400E-01
Weekly Drinker-vs-Social Drinker
2.004800E-01
Occasional Drinker-vs-Social Drinker
8.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.927600E-02
Normal-vs-Grade 2
4.377100E-03
Normal-vs-Grade 3
1.061620E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.913200E-01
Grade 1-vs-Grade 3
1.678800E-01
Grade 1-vs-Grade 4
3.927600E-02
Grade 2-vs-Grade 3
4.314600E-01
Grade 2-vs-Grade 4
4.377100E-03
Grade 3-vs-Grade 4
1.061620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.447600E-02
Normal-vs-NonDiabetic
1.633790E-01
Diabetic-vs-NonDiabetic
2.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.995600E-02
Normal-vs-NoPancreatitis
1.365790E-01
Pancreatitis-vs-NoPancreatitis
6.748800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.863600E-01
Normal-vs-N1
1.887780E-01
N0-vs-N1
9.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.805600E-01
Normal-vs-TP53-NonMutant
3.524200E-01
TP53-Mutant-vs-TP53-NonMutant
7.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
